Colorectal cancer

@article{Cunningham2010ColorectalC,
  title={Colorectal cancer},
  author={D. Cunningham and W. Atkin and H. Lenz and H. Lynch and B. Minsky and B. Nordlinger and N. Starling},
  journal={The Lancet},
  year={2010},
  volume={375},
  pages={1030-1047}
}
Substantial progress has been made in colorectal cancer in the past decade. Screening, used to identify individuals at an early stage, has improved outcome. There is greater understanding of the genetic basis of inherited colorectal cancer and identification of patients at risk. Optimisation of surgery for patients with localised disease has had a major effect on survival at 5 years and 10 years. For rectal cancer, identification of patients at greatest risk of local failure is important in the… Expand
Improving outcomes in colorectal cancer: where do we go from here?
Microsatellite instability & survival in patients with stage II/III colorectal carcinoma
Managing advanced colorectal cancer: have we reached the PEAK with current therapies?
  • B. Wolpin, A. Bass
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2014
Personalisation of therapy in advanced colorectal cancer
Metastatic Colorectal Cancer and the Need for More Endoscopic Tools
AC133 expression associated with poor prognosis in stage II colorectal cancer
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 137 REFERENCES
Actual 10-year survival after resection of colorectal liver metastases defines cure.
Clinical management of hereditary colorectal cancer syndromes
Complete response of colorectal liver metastases after chemotherapy: does it mean cure?
Molecular tests for colorectal cancer screening.
...
1
2
3
4
5
...